Catyalyst Pharmaceutical (CPRX) Posts Q3 Loss of 6c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Nasdaq ticks up as tech stocks steady; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude jumps to highest since April on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Tweet
Share
E-mailGet Alerts CPRX Hot Sheet
Price: $31.49 --0%
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Financial Fact:
Total operating costs and expenses: 3.91M
Today's EPS Names:
FCNCA, FCNCA, RCBC, More
Join SI Premium – FREE
Catyalyst Pharmaceutical (NASDAQ: CPRX) reported Q3 EPS of ($0.06), $0.01 worse than the analyst estimate of ($0.05).
For earnings history and earnings-related data on Catyalyst Pharmaceutical (CPRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AI-powered cyber threats light a fire under cybersecurity stocks
- Nokia shares recover after analysts call selloff overdone
- AI chip sell-off is ‘unmoored from fundamentals,’ LYNX says
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
